TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 0 | -0 | 1 | -4 | -9 | -19 | -5 |
| S | %wins | 67 | 67 | 33 | 67 | 33 | 67 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/11 18:02 | 5/6/11 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Boyer Herbert W Ph D | CA | D | S.dm | -9,720 | 81.00 | 33 | -120 | -93 | 10 | M | 111 | 52 | 23 | 13 | 13 | 9 | 2 | 1 | 0 | 1 | 3 | -4 | 3 | 17 | |
4/26/05 17:19 | 4/22/05 | DNA | Genentech Inc | DE | Health | Drug | Pharmaceutical Preparations | Boyer Herbert W Ph D | CA | D | S.d | -1,960 | 70.00 | 0 | -28 | -50 | 28 | D | |||||||||||||||
4/18/05 20:48 | 4/15/05 | DNA | Genentech Inc | DE | Health | Drug | Pharmaceutical Preparations | Boyer Herbert W Ph D | CA | D | S.d | -1,310 | 65.50 | 0 | -20 | -42 | 28 | D | |||||||||||||||
5/7/04 16:52 | 5/5/04 | DNA | Genentech Inc | DE | Health | Drug | Pharmaceutical Preparations | Boyer Herbert W Ph D | CA | D | S.d | -1,250 | 125.00 | 0 | -10 | -42 | 14 | D | |||||||||||||||
1/28/04 17:37 | 1/26/04 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Boyer Herbert W Ph D | CA | D | S | -425 | 85.00 | 33 | -5 | -22 | 17 | I | 55 | 62 | 16 | 16 | 4 | 4 | 0 | -3 | 1 | 0 | -2 | -10 | -47 | -37 | |
7/30/03 17:45 | 7/29/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Boyer Herbert W Ph D | CA | D | S | -400 | 80.00 | 33 | -5 | -18 | 22 | I | -35 | 104 | 37 | 39 | -5 | -6 | 0 | 0 | 0 | -2 | 2 | 1 | 18 | -36 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |